Idiopathic Thrombocytopenic Purpura (ITP): Immunomodulation by Intravenous Immunoglobulin (IVIg)

References

• Harrington W. J., Minnich V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J. Lab. Clin 1951; 38: 1–10
   PubMed Web of Science ®Google Scholar
• Imbach P., d'Apuzzo V., Hirt A. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228
   PubMed Web of Science ®Google Scholar
• Bussel J. B., Hilgartner M. The use of and mechanism of action of high dose intravenous immunoglobulin in the treatment of immune haematologic disease. Br. J. Haematol 1984; 56: 1–7
   PubMed Web of Science ®Google Scholar
• Fehr J., Hofmann V., Kappcler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N. Engl. J. Med 1982; 306: 1254
   PubMed Web of Science ®Google Scholar
• Newland A. C., Veys P. A., Macey M. G., Gutleridge C. N., Bussel J. B., Cunningham-Rundles C. The use of intravenous immunoglobulin in autoimmune haemolytic anaemia. Medicine 1988, (in press)
   Google Scholar
• Pollack S., Cunningham-Rundles C., Smithwick E. M. High dose intravenous gammaglobulin for autoimmune neutropenia. N. Engl. J. Med 1982; 307: 253
   PubMed Web of Science ®Google Scholar
• Stiehm R. E., Ashida E., Kim K. S., Winston D. J., Haas A., Gale R. P. Intravenous immunoglobulins as therapeutic agents. Ann Int. Med 1987; 107: 367–382
   PubMed Web of Science ®Google Scholar
• Stuart M. J., Kelton J. G. Techniques used to measure platelet antibodies. Hematology of infancy and childhood, 3rd ed, D C Nathan, FA Oski. W.B. Saunders, Philadelphia 1987; 1399–1406
   Google Scholar
• Van Leeuwen E. F., Van der Ven J. T. H., Engelfriet C. P., Von dem Borne A. E. G. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982; 59: 23
   PubMed Web of Science ®Google Scholar
• Woods V. L., Oh E. H., Mason D., McMillan R. Autoantibodies against the platelet glycoprotein IIb/I IIa complex in patients with chronic ITP. Blood 1984; 63: 368
   PubMed Web of Science ®Google Scholar
• Woods V. L., Kurata Y., Montgomery R. R., Tani P., Mason D., Oh E. H., McMillan R. Autoantibodies against platelet glycoprotein Ib in patients with chronic idiopathic purpura. Blood 1984; 64: 156
   PubMed Web of Science ®Google Scholar
• McMillan R., Tani P., Millard F., Berchtold P., Renshaw Woods L. V. L., Jr. Platelet-associated and plasma anti-glyco-protein autoantibodies in chronic ITP. Blood 1987; 70: 1040–1045
   PubMed Web of Science ®Google Scholar
• Imbach P., Wagner H. P., Berchtold W., Gaedicke G., Hirt A., Joller P. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; 2: 464–468
   PubMed Web of Science ®Google Scholar
• Imholz B., Imbach P., Baumgartner C. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study. Blut 1988; 56: 63–68
   PubMedGoogle Scholar
• Budde U., Harbrecht U. Platelet kinetics after high dose intravenous gammaglobulin. Thromb. Haemost 1984; 3: 412
   Google Scholar
• Uchida T., Yui T., Umezu H. Prolongation of platelet survival in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. Thromb. Haemost 1984; 51: 65
   PubMedGoogle Scholar
• Schmidt K. G., Rasmussen J. W., Diederichsen H. Release of platelets into the circulation induced by gammaglobulin treatment in a case of idiopathic thrombocytopenic purpura. Blut 1984; 48: 27
   PubMedGoogle Scholar
• Burdach S. E. G., Guersen R. G. Mechanism of intravenous immunoglobulin treatment in childhood acute idiopathic thrombocytopenic purpura. Comparison of F(ab)2 versus Fc containing IgG. Pediatr. Res. 1985; 19: 259-A
   Google Scholar
• Tovo P. A., Miniero R., Fiandino G. Fc-depleted vs intact intravenous immunoglobulin in chronic ITP. J. Pediatr 1984; 105: 676
   PubMedGoogle Scholar
• Salama A., Kiefel V., Amberg R. Treatment of autoimmune thrombocytopenic purpura with Rhesus antibodies (anti-Rho (D)). Blut 1984; 49: 29
   PubMedGoogle Scholar
• Müller-Eckhardt C., Salama A., Kiefel V. A new concept for the effector mechanism of intravenous immunoglohulin in hemocytopenias. Blut 1984; 48: 353
   PubMedGoogle Scholar
• Clarkson S. B., Bussel J. B., Kimberly R. P., Valinsky J. E., Nachmann R. L., Unkeless J. C. Treatment of refractory immune thrombocytopenic purpura with an anti Fc receptor antibody. N. Engl. J. Med 1986; 314: 1236–1239
   PubMed Web of Science ®Google Scholar
• Newland A. C., Macey M. B., Veys P. A. Cellular changes during the infusion of high dose intravenous immunoglobulin. Blut, (in press)
   Google Scholar
• Sinclair N. R.St. C., Panoskaltsis A. Immunoregulation by Fc signals. Immunology Today 1987; 8: 76–79
   PubMedGoogle Scholar
• Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of auto antibodies to Factor VIII anti-haemophilic factor by high dose intravenous gammaglobulin. Lancet 1985; 11: 765–768
   Google Scholar
• Fateh-Moghadem A., Wick M., Besinger U., Geursen R. G. High dose intravenous gammaglobulin for myasthenia gravi. Lancet 1984; 1: 848–849
   Google Scholar
• McVerry B. A., Spearing R., Smith A. SLE anticoagulant; transient inhibition by high dose immunoglobulin infusion. Br. J Haematol 1985; 9: 49–58
   Google Scholar
• Nydegger U. E., Blaser K., Hassig A. Antiidiotypic immunosuppression and its treatment with human immunoglobulin preparations. Vox Sang 1984; 47: 92
   PubMedGoogle Scholar
• Rossi F., Kazatchkine M. D. Suppression anti-idiotypique d'arte anticorps pas les immunoglobulines normales polyspecifiques (abstract). serum U 28, Hôpital Broussars, Paris, France.
   Google Scholar
• McGuire W. A., Yang H. H., Bruno E. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gammaglobulin. N. Engl J. Med 1987; 317: 1004–1008
   PubMedGoogle Scholar
• Bussell J. B., Skvaril F., Morell A. Selective IgG2 deficiency in patients with ITP. Blood 1984; 64(suppl. 1)235a
   Google Scholar
• Morell A., Skvaril F., Barandun S. Serum concentrations of IgG subclasses. Clinical Immunabiology, vol 3, S H Bach, R A Good. Academic Press, New York 1976; 37
   Google Scholar
• Winiarski J., Kreuger A., Ejderhamm J. High-dose intravenous IgG reduces platelet-associated immunoglobulins and complement in idiopathic thrombocytopenic purpura. Scand. J. Haematol 1983; 31: 342
   PubMedGoogle Scholar
• Gross B., Hässig A., Lüscher E. F., Nydegger V. E. Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG. Brit J. Haemat 1983; 53: 289–299
   PubMed Web of Science ®Google Scholar